Open
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$89.85K

Rothblatt Martine A Chairperson & CEO

Transaction date Nov 9, 2026
Public filing date Nov 10, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$582.46 Nov 9, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
161 shares @ $558.07
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000184
Filing cohort

Transactions in this filing

Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.63M
Buys / sales
0 / 24
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Nov 9, 2026 $39.75K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $136.61K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $69.29K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $302.39K
United Therapeutics Corp UTHR Exercise Nov 9, 2026 $0
United Therapeutics Corp UTHR Exercise Nov 9, 2026 $1.12M
United Therapeutics Corp UTHR Sale Nov 9, 2026 $44.52K
United Therapeutics Corp UTHR Current Sale Nov 9, 2026 $89.85K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $287.92K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $163.98K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $1.01M
United Therapeutics Corp UTHR Sale Nov 9, 2026 $93.86K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $290.11K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $90.3K
United Therapeutics Corp UTHR Sale Nov 9, 2026 $124.42K